Bank of New York Mellon
GRNA

Bank of New York Mellon’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Bank of New York Mellon’s Portfolio GRNA Stock Details GRNA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$7.49K Sell
2023
Q1 		$107K Buy
2022
Q4 		$283K Buy
2022
Q3 		$495K Buy
2022
Q2 		$107K Buy
2022
Q1 		$245K Buy